Extended-release monthly buprenorphine injection

CMAJ. 2023 Jan 9;195(1):E14. doi: 10.1503/cmaj.220730.

Authors

Ari B Cuperfain¹, Tianna Costa¹, Nitin Chopra²

Affiliations

¹ Department of Psychiatry (Cuperfain, Chopra) and Centre for Addiction and Mental Health (Costa, Chopra), University of Toronto, Toronto, Ont.
² Department of Psychiatry (Cuperfain, Chopra) and Centre for Addiction and Mental Health (Costa, Chopra), University of Toronto, Toronto, Ont. nitin.chopra@camh.ca.

No abstract available

MeSH terms

Analgesics, Opioid / therapeutic use
Buprenorphine* / therapeutic use
Delayed-Action Preparations / therapeutic use
Humans
Narcotic Antagonists / therapeutic use
Opioid-Related Disorders* / drug therapy

Substances

Buprenorphine
Narcotic Antagonists
Delayed-Action Preparations
Analgesics, Opioid